Late-Onset Scleroderma Renal Crisis Does Occur - A Multi-Center Study.

IF 3.3 2区 医学 Q1 RHEUMATOLOGY
Swati Mehta, Sumbal Wajid, Isam Albaba, Virginia Steen, Robyn T Domsic-Degazio, Alexa Luta, Paul J Feustel, Loay Salman, Lee Shapiro
{"title":"Late-Onset Scleroderma Renal Crisis Does Occur - A Multi-Center Study.","authors":"Swati Mehta, Sumbal Wajid, Isam Albaba, Virginia Steen, Robyn T Domsic-Degazio, Alexa Luta, Paul J Feustel, Loay Salman, Lee Shapiro","doi":"10.1002/acr.25608","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Scleroderma renal crisis (SRC) is historically described to occur within first 5 years of SSc diagnosis. However, it has been observed to occur beyond 5 years. In this analysis, we aim to describe the prevalence, clinical features and outcomes of late onset SRC and compare them to early onset SRC.</p><p><strong>Methods: </strong>This retrospective observational study included patients diagnosed with SRC between 1995 to 2018 at three university-affiliated hospitals. Late onset SRC was defined as SRC occurring 5 years after SSc diagnosis. After obtaining IRB approval, data including demographics, SRC onset, clinical characteristics, laboratory data, and outcomes were extracted. Continuous data were expressed as mean/median, and categorical as frequencies/percentages. Differences were analyzed via Pearson's chi-square.</p><p><strong>Results: </strong>A total of 223 SRC patients were identified, with 169 (75.8%) classified as early onset and 54 (24.2%) as late onset. Late onset group had a mean SRC onset at 12.2 years after SSc diagnosis. Male predominance was observed in late compared to early group (59% vs 9%). Steroid exposure was more common in late vs early group (56% vs 29%). There was no evidence of difference in autoantibodies profile and outcomes between early and late onset groups.</p><p><strong>Conclusions: </strong>Late onset SRC was seen in up to 25% of SRC patients, with a mean of 12 years after SSc diagnosis. Our findings reveal comparable clinical characteristics and outcomes between early and late onset SRC, underlying the importance of recognizing SRC regardless of disease duration to optimize outcomes.</p>","PeriodicalId":8406,"journal":{"name":"Arthritis Care & Research","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthritis Care & Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/acr.25608","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Scleroderma renal crisis (SRC) is historically described to occur within first 5 years of SSc diagnosis. However, it has been observed to occur beyond 5 years. In this analysis, we aim to describe the prevalence, clinical features and outcomes of late onset SRC and compare them to early onset SRC.

Methods: This retrospective observational study included patients diagnosed with SRC between 1995 to 2018 at three university-affiliated hospitals. Late onset SRC was defined as SRC occurring 5 years after SSc diagnosis. After obtaining IRB approval, data including demographics, SRC onset, clinical characteristics, laboratory data, and outcomes were extracted. Continuous data were expressed as mean/median, and categorical as frequencies/percentages. Differences were analyzed via Pearson's chi-square.

Results: A total of 223 SRC patients were identified, with 169 (75.8%) classified as early onset and 54 (24.2%) as late onset. Late onset group had a mean SRC onset at 12.2 years after SSc diagnosis. Male predominance was observed in late compared to early group (59% vs 9%). Steroid exposure was more common in late vs early group (56% vs 29%). There was no evidence of difference in autoantibodies profile and outcomes between early and late onset groups.

Conclusions: Late onset SRC was seen in up to 25% of SRC patients, with a mean of 12 years after SSc diagnosis. Our findings reveal comparable clinical characteristics and outcomes between early and late onset SRC, underlying the importance of recognizing SRC regardless of disease duration to optimize outcomes.

迟发性硬皮病肾危象确实发生-一项多中心研究。
目的:硬皮病肾危象(SRC)历史上被描述为发生在SSc诊断的前5年内。然而,它已经被观察到发生在5年以上。在本分析中,我们旨在描述迟发性SRC的患病率、临床特征和预后,并将其与早发性SRC进行比较。方法:本回顾性观察研究纳入了1995年至2018年在三所大学附属医院诊断为SRC的患者。迟发性SRC定义为在SSc诊断后5年发生的SRC。在获得IRB批准后,提取包括人口统计学、SRC发病、临床特征、实验室数据和结果在内的数据。连续数据以平均值/中位数表示,分类数据以频率/百分比表示。通过皮尔逊卡方分析差异。结果:共发现223例SRC患者,其中早发性169例(75.8%),晚发性54例(24.2%)。晚发组的SRC平均发病时间为SSc诊断后12.2年。与早期组相比,男性在晚期组中占优势(59%对9%)。类固醇暴露在晚期组比早期组更常见(56%对29%)。没有证据表明早发组和晚发组在自身抗体谱和结果上存在差异。结论:迟发性SRC见于高达25%的SRC患者,平均为确诊后12年。我们的研究结果揭示了早期和晚发性SRC的临床特征和结果的可比性,这表明无论病程如何,识别SRC对于优化预后的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.40
自引率
6.40%
发文量
368
审稿时长
3-6 weeks
期刊介绍: Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals (a division of the College), is a peer-reviewed publication that publishes original research, review articles, and editorials that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with rheumatic diseases, major topics are evidence-based practice studies, clinical problems, practice guidelines, educational, social, and public health issues, health economics, health care policy, and future trends in rheumatology practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信